Novartis develops and markets innovative prescription medicines in areas including oncology, cardiovascular diseases, neuroscience, and immunology. The company focuses on research and development of new therapies, including advanced biologics and targeted treatments. It serves patients worldwide through its pharmaceutical products and collaborations with healthcare providers.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 13,620 | — | 3,606 | -2.2% |
| Q2 2025 | 14,836 | — | 4,041 | 0% |
| Q3 2025 | 14,358 | — | 3,928 | -5.9% |
| Q4 2025 | 13,860 | — | 2,409 | -39.8% |
| Q1 2026 | 13,524 | -0.7% | 3,156 | -12.5% |
| Q2 2026 | 14,951 | 0.8% | 3,264 | -19.2% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Morgan Stanley (MS), Royal Bank of Canada (RY), Alibaba Group Holding Limited (BABA), RTX Corporation (RTX), SAP SE (SAP), The Goldman Sachs Group, Inc. (GS)